Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion type Assertion NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_head.
- NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion description "[On the other hand, p42/44-MAPK activation induced by EGF stimulation was only slightly reduced (75% in SRS fibroblasts in comparison with control), suggesting a general impairment in MAPK pathway with a greater impairment of the stimulation induced by insulin and IGF1 than by EGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_provenance.
- NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion evidence source_evidence_literature NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_provenance.
- NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion SIO_000772 22170793 NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_provenance.
- NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion wasDerivedFrom befree-20140225 NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_provenance.
- NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_assertion wasGeneratedBy ECO_0000203 NP807820.RAN3V44Lgq3-vV9eD5_in4wZ_EsSr7DKaHVkv4xRSavP8130_provenance.